ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
CytomX Therapeutics Inc

CytomX Therapeutics Inc (CTMX)

0,6579
0,0076
( 1,17% )
Aktualisiert: 21:27:11
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,6579
Gebot
0,6579
Fragen
0,6646
Volumen
286.183
0,6011 Tagesbereich 0,6613
0,6011 52-Wochen-Bereich 5,85
Marktkapitalisierung
Handelsende
0,6503
Handelsbeginn
0,6387
Letzte Trade
1734
@
0.6579
Letzter Handelszeitpunkt
21:27:11
Finanzvolumen
US$ 180.779
VWAP
0,631689
Durchschnittliches Volumen (3 Mio.)
896.464
Ausgegebene Aktien
78.258.879
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-89,04
Gewinn pro Aktie (EPS)
-0,01
Erlöse
101,21M
Nettogewinn
-569k

Über CytomX Therapeutics Inc

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clini... CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Dover, Delaware, USA
Gegründet
-
CytomX Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CTMX. The last closing price for CytomX Therapeutics was US$0,65. Over the last year, CytomX Therapeutics shares have traded in a share price range of US$ 0,6011 to US$ 5,85.

CytomX Therapeutics currently has 78.258.879 shares in issue. The market capitalisation of CytomX Therapeutics is US$50,89 million. CytomX Therapeutics has a price to earnings ratio (PE ratio) of -89.04.

CTMX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0711-9.753086419750.7290.740.60115871040.67812257CS
4-0.1921-22.60.850.980.60116694700.78399167CS
12-0.5821-46.94354838711.241.250.60118964640.94052284CS
26-0.4621-41.25892857141.121.420.60119989501.05263181CS
52-2.0421-75.63333333332.75.850.601124033303.10006778CS
156-3.1021-82.50265957453.765.850.601115105842.55590758CS
260-6.6521-917.3115.440.601112019133.6436493CS

CTMX - Frequently Asked Questions (FAQ)

What is the current CytomX Therapeutics share price?
The current share price of CytomX Therapeutics is US$ 0,6579
How many CytomX Therapeutics shares are in issue?
CytomX Therapeutics has 78.258.879 shares in issue
What is the market cap of CytomX Therapeutics?
The market capitalisation of CytomX Therapeutics is USD 50,89M
What is the 1 year trading range for CytomX Therapeutics share price?
CytomX Therapeutics has traded in the range of US$ 0,6011 to US$ 5,85 during the past year
What is the PE ratio of CytomX Therapeutics?
The price to earnings ratio of CytomX Therapeutics is -89,04
What is the cash to sales ratio of CytomX Therapeutics?
The cash to sales ratio of CytomX Therapeutics is 0,5
What is the reporting currency for CytomX Therapeutics?
CytomX Therapeutics reports financial results in USD
What is the latest annual turnover for CytomX Therapeutics?
The latest annual turnover of CytomX Therapeutics is USD 101,21M
What is the latest annual profit for CytomX Therapeutics?
The latest annual profit of CytomX Therapeutics is USD -569k
What is the registered address of CytomX Therapeutics?
The registered address for CytomX Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the CytomX Therapeutics website address?
The website address for CytomX Therapeutics is www.cytomx.com
Which industry sector does CytomX Therapeutics operate in?
CytomX Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MASS908 Devices Inc
US$ 3,9101
(97,48%)
116,86M
RAPPRapport Therapeutics Inc
US$ 10,715
(49,86%)
944,19k
FRGTFreight Technologies Inc
US$ 1,51
(46,60%)
74,82M
JZXNJiuzi Holdings Inc
US$ 4,15
(36,51%)
89,28k
HOTHHoth Therapeutics Inc
US$ 1,145
(31,61%)
7,31M
AGHAureus Greenway Holdings Inc
US$ 0,77
(-64,52%)
3,14M
PSTVPlus Therapeutics Inc
US$ 0,2941
(-55,44%)
4,36M
NKGNNKGen Biotech Inc
US$ 0,2512
(-51,30%)
5,57M
TNYATenaya Therapeutics Inc
US$ 0,497575
(-47,45%)
21,81M
PCLAPicoCELA Inc
US$ 1,655
(-47,12%)
1,04M
NVDANVIDIA Corporation
US$ 119,09
(4,41%)
331,8M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12,56
(-0,87%)
168,99M
BTOGBit Origin Ltd
US$ 0,3658
(14,56%)
127,61M
UOKAMDJM Ltd
US$ 0,1729
(15,27%)
124,95M
INTCIntel Corporation
US$ 22,08
(-2,90%)
122,01M

CTMX Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock